Media ReleasesInnate Immunotherapeutics

View All Innate Immunotherapeutics News


Multiple abstracts concerning MIS416 mechanism of action accepted for presentation at upcoming American Academy of Neurologists meeting

Innate Immunotherapeutics Limited (ASX Code: IIL), together with a number of Australian, Canadian, and Danish scientific collaborators, has had multiple abstracts accepted for presentation at the American Academy of Neurologists (AAN) Annual Meeting being held in Boston in late April.

The AAN Annual Meeting is the world's largest gathering of neurologists, bringing together more than 10,000 neurology professionals across the globe to network, discuss cutting-edge research, and take part in top-rated education programming across a wide variety of topics.

For further information please download PDF attached:
Download this document

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?